These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2069028)

  • 21. Species differences in the hepatic microsomal enzyme metabolism of the pyrrolizidine alkaloids.
    Huan JY; Miranda CL; Buhler DR; Cheeke PR
    Toxicol Lett; 1998 Oct; 99(2):127-37. PubMed ID: 9817084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting the chronic hepatotoxicity of pyrrolizidine alkaloids.
    Jago MV
    J Pathol; 1971 Sep; 105(1):1-11. PubMed ID: 5129752
    [No Abstract]   [Full Text] [Related]  

  • 23. The roles of CYP3A and CYP2B isoforms in hepatic bioactivation and detoxification of the pyrrolizidine alkaloid senecionine in sheep and hamsters.
    Huan JY; Miranda CL; Buhler DR; Cheeke PR
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):229-35. PubMed ID: 9707499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. trans-4-Hydroxy-2-hexenal: a reactive metabolite from the macrocyclic pyrrolizidine alkaloid senecionine.
    Segall HJ; Wilson DW; Dallas JL; Haddon WF
    Science; 1985 Aug; 229(4712):472-5. PubMed ID: 4012327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological reactive intermediates of pyrrolizidine alkaloids.
    Buhler DR; Kedzierski B
    Adv Exp Med Biol; 1986; 197():611-20. PubMed ID: 3766284
    [No Abstract]   [Full Text] [Related]  

  • 26. Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Lafranconi WM; Ohkuma S; Huxtable RJ
    Toxicon; 1985; 23(6):983-92. PubMed ID: 3938082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Configuration of necine pyrroles--toxic metabolites of pyrrolizidine alkaloids.
    Kedzierski B; Buhler DR
    Toxicol Lett; 1985 May; 25(2):115-9. PubMed ID: 4002242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Study of Hepatotoxicity of Pyrrolizidine Alkaloids Retrorsine and Monocrotaline.
    Yang X; Li W; Sun Y; Guo X; Huang W; Peng Y; Zheng J
    Chem Res Toxicol; 2017 Feb; 30(2):532-539. PubMed ID: 28095673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsomal metabolism of pyrrolizidine alkaloids: N-oxidation of seneciphylline and senecionine.
    Ramsdell HS; Buhler DR
    Toxicol Lett; 1987 Aug; 37(3):241-9. PubMed ID: 3617098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine.
    Xia Q; Chou MW; Edgar JA; Doerge DR; Fu PP
    Cancer Lett; 2006 Jan; 231(1):138-45. PubMed ID: 16356839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum copper concentration in monocrotaline pyrrole treated rats with pulmonary hypertension.
    Ganey PE; Roth RA
    Biochem Pharmacol; 1987 Oct; 36(20):3535-7. PubMed ID: 3675611
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of glutathione and cysteine on pyrrolizidine alkaloid-induced hepatotoxicity and DNA adduct formation in rat primary hepatocytes.
    He X; Xia Q; Shi Q; Fu PP
    J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):109-123. PubMed ID: 32500832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red blood cells augment transport of reactive metabolites of monocrotaline from liver to lung in isolated and tandem liver and lung preparations.
    Pan LC; Lamé MW; Morin D; Wilson DW; Segall HJ
    Toxicol Appl Pharmacol; 1991 Sep; 110(2):336-46. PubMed ID: 1909819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the pneumotoxicity of some pyrrolic esters and similar compounds analogous to pyrrolizidine alkaloid metabolites, given intravenously to rats.
    Mattocks AR; Driver HE
    Toxicology; 1983 Jun; 27(2):159-77. PubMed ID: 6612746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver.
    Mattocks AR; Croswell S; Jukes R; Huxtable RJ
    Toxicon; 1991; 29(4-5):409-15. PubMed ID: 1907409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity.
    Xia Q; Zhao Y; Von Tungeln LS; Doerge DR; Lin G; Cai L; Fu PP
    Chem Res Toxicol; 2013 Sep; 26(9):1384-96. PubMed ID: 23937665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline.
    Lamé MW; Morin D; Jones AD; Segall HJ; Wilson DW
    Toxicol Lett; 1990 May; 51(3):321-9. PubMed ID: 2111054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro biotransformation of pyrrolizidine alkaloids in different species: part II-identification and quantitative assessment of the metabolite profile of six structurally different pyrrolizidine alkaloids.
    Geburek I; Schrenk D; These A
    Arch Toxicol; 2020 Nov; 94(11):3759-3774. PubMed ID: 32880719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deacetylclivorine: a gender-selective metabolite of clivorine formed in female Sprague-Dawley rat liver microsomes.
    Lin G; Tang J; Liu XQ; Jiang Y; Zheng J
    Drug Metab Dispos; 2007 Apr; 35(4):607-13. PubMed ID: 17237157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-related inhibition of the drug-metabolizing enzymes of rat liver by the pyrrolizidine alkaloid, monocrotaline.
    Dalvi RR
    J Pharm Pharmacol; 1987 May; 39(5):386-8. PubMed ID: 2886588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.